Home
About
Overview
Sharing Data
ORCID
Help
History (1)
FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer.
FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer. Front Immunol. 2020; 11:575258.
View in:
PubMed
subject areas
Animals
Biomarkers, Tumor
Clinical Decision-Making
Humans
Immunotherapy
Molecular Targeted Therapy
Prognosis
Receptor, Fibroblast Growth Factor, Type 3
Urinary Bladder Neoplasms
Urothelium
authors with profiles
Randy Sweis